Stocktoria
INTEGRA LIFESCIENCES HOLDINGS CORP IART
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1995-08-16
INTEGRA LIFESCIENCES HOLDINGS CORP statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -30.2% | 1.8% | 7.2% | 15.3% | 12.8% |
| Net margin | -31.6% | -0.4% | 4.4% | 11.6% | 11.0% |
| FCF margin | -1.9% | 1.6% | 4.7% | 14.3% | 17.1% |
| Return on assets | -14.3% | -0.2% | 1.8% | 4.6% | 4.5% |
| Return on equity | -49.5% | -0.4% | 4.3% | 10.0% | 10.0% |
| Debt / equity | 0.70× | 0.49× | 0.49× | 0.43× | 0.50× |
| Current ratio | 2.54 | 1.17 | 3.45 | 3.62 | 3.39 |
| Revenue growth | 1.5% | 4.5% | -1.0% | 1.0% | 12.4% |
Source: SEC EDGAR filings · CIK 0000917520 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.